Annaly Capital Management Valuation
Is NLY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NLY?
Other financial metrics that can be useful for relative valuation.
What is NLY's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | US$9.69b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does NLY's PB Ratio compare to its peers?
Company | PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.8x | ||
BXMT Blackstone Mortgage Trust | 0.7x | 14.5% | US$3.2b |
STWD Starwood Property Trust | 0.9x | 15.6% | US$5.7b |
RITM Rithm Capital | 0.7x | 29.6% | US$4.2b |
ABR Arbor Realty Trust | 1x | 5.6% | US$2.6b |
NLY Annaly Capital Management | 0.9x | 143.0% | US$9.7b |
Price-To-Book vs Peers: NLY is expensive based on its Price-To-Book Ratio (0.9x) compared to the peer average (0.8x).
Price to Earnings Ratio vs Industry
How does NLY's PE Ratio compare vs other companies in the US Mortgage REITs Industry?
Price-To-Book vs Industry: NLY is expensive based on its Price-To-Book Ratio (0.9x) compared to the US Mortgage REITs industry average (0.7x)
Price to Book Ratio vs Fair Ratio
What is NLY's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | 0.9x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate NLY's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of NLY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NLY ($19.61) is trading below our estimate of fair value ($21.98)
Significantly Below Fair Value: NLY is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | US$19.61 | US$21.56 +10.0% | 4.1% | US$23.50 | US$20.50 | n/a | 8 |
May ’24 | US$19.32 | US$21.89 +13.3% | 5.6% | US$24.00 | US$20.00 | n/a | 9 |
Apr ’24 | US$19.11 | US$22.78 +19.2% | 5.7% | US$24.50 | US$20.00 | n/a | 9 |
Mar ’24 | US$20.14 | US$23.03 +14.3% | 3.8% | US$24.50 | US$22.00 | n/a | 9 |
Feb ’24 | US$24.00 | US$22.08 -8.0% | 8.0% | US$24.50 | US$18.50 | n/a | 9 |
Jan ’24 | US$21.08 | US$20.00 -5.1% | 7.3% | US$23.00 | US$18.50 | n/a | 9 |
Dec ’23 | US$21.88 | US$19.39 -11.4% | 3.4% | US$20.50 | US$18.50 | n/a | 9 |
Nov ’23 | US$18.42 | US$19.22 +4.4% | 4.1% | US$20.50 | US$18.00 | n/a | 9 |
Oct ’23 | US$17.16 | US$25.11 +46.3% | 9.8% | US$28.00 | US$19.00 | n/a | 9 |
Sep ’23 | US$25.52 | US$26.33 +3.2% | 5.7% | US$28.00 | US$24.00 | n/a | 9 |
Aug ’23 | US$27.60 | US$26.38 -4.4% | 6.0% | US$28.00 | US$24.00 | n/a | 8 |
Jul ’23 | US$24.32 | US$25.89 +6.5% | 5.9% | US$28.00 | US$24.00 | n/a | 9 |
Jun ’23 | US$26.40 | US$25.89 -1.9% | 5.3% | US$28.00 | US$24.00 | US$19.43 | 9 |
May ’23 | US$25.68 | US$26.56 +3.4% | 8.9% | US$32.00 | US$24.00 | US$19.32 | 9 |
Apr ’23 | US$28.24 | US$30.89 +9.4% | 4.2% | US$33.00 | US$29.00 | US$19.11 | 9 |
Mar ’23 | US$27.88 | US$30.89 +10.8% | 4.2% | US$33.00 | US$29.00 | US$20.14 | 9 |
Feb ’23 | US$31.56 | US$34.30 +8.7% | 7.0% | US$38.00 | US$30.00 | US$24.00 | 10 |
Jan ’23 | US$31.28 | US$35.45 +13.3% | 5.0% | US$38.00 | US$32.00 | US$21.08 | 11 |
Dec ’22 | US$31.92 | US$35.64 +11.6% | 4.2% | US$38.00 | US$34.00 | US$21.88 | 11 |
Nov ’22 | US$34.48 | US$35.73 +3.6% | 4.0% | US$38.00 | US$34.00 | US$18.42 | 11 |
Oct ’22 | US$33.84 | US$35.91 +6.1% | 3.7% | US$38.00 | US$34.00 | US$17.16 | 11 |
Sep ’22 | US$34.92 | US$35.91 +2.8% | 3.7% | US$38.00 | US$34.00 | US$25.52 | 11 |
Aug ’22 | US$33.96 | US$36.27 +6.8% | 3.1% | US$38.00 | US$34.00 | US$27.60 | 11 |
Jul ’22 | US$35.68 | US$37.18 +4.2% | 3.4% | US$40.00 | US$36.00 | US$24.32 | 11 |
Jun ’22 | US$37.68 | US$37.00 -1.8% | 3.6% | US$39.00 | US$34.00 | US$26.40 | 11 |
Analyst Forecast: Target price is less than 20% higher than the current share price.